Showing results (81-90 of 123) with videos related to
Sort By:
Pageof 13
The American Journal of Medicine|April 27, 2024
Social Networks as a Key Health Determinant in Acute Illness Recovery: A Lesson from the COVID-19 PandemicDi Pan, Jihui L Diaz, Karissa Weidman, et al.Surgical Endoscopy|March 26, 2017
Underwater endoscopic mucosal resection is associated with fewer recurrences and earlier curative resections compared to conventional endoscopic mucosal resection for large colorectal polypsRobert J Schenck, Darius A Jahann, James T Patrie, et al.Plos One|July 24, 2020
Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 diseaseMichael J Satlin, Parag Goyal, Reed Magleby, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 20, 2014
Lysophosphatidic acid and apolipoprotein A1 predict increased risk of developing World Trade Center-lung injury: a nested case-control studyJun Tsukiji, Soo Jung Cho, Ghislaine C Echevarria, et al.Critical Care (London, England)|March 27, 2017
Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unitEli J Finkelsztein, Daniel S Jones, Kevin C Ma, et al.JCI Insight|May 3, 2019
Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsisEdward J Schenck, Kevin C Ma, David R Price, et al.Annals of the American Thoracic Society|March 24, 2021
A Comparative Analysis of the Respiratory Subscore of the Sequential Organ Failure Assessment Scoring SystemEdward J Schenck, Katherine L Hoffman, Clara Oromendia, et al.Plos One|March 19, 2025
Three hospitalized non-critical COVID-19 subphenotypes and change in intubation or death over time: A latent class analysis with external and longitudinal validationWilliam S Stringer, Amy S Labar, Joshua D Geleris, et al.Bioorganic & Medicinal Chemistry Letters|September 17, 2011
Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonistCharles E Mowbray, Andrew S Bell, Nicholas P Clarke, et al.Nature Communications|April 7, 2023
Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiativeChengxi Zang, Yongkang Zhang, Jie Xu, et al.Pageof 13